Evidence map›Paper›PMID 23420845›Full record

ArticleThe Journal of biological chemistry2013

A new way to degrade heme: the Mycobacterium tuberculosis enzyme MhuD catalyzes heme degradation without generating CO.

Shusuke Nambu, Toshitaka Matsui, Celia W Goulding, Satoshi Takahashi, Masao Ikeda-Saito

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 107 citations in OpenAlex.

  1. Mechanism of Enhancement by the FeChemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. HemU and TonB1 contribute to hemin acquisition inFrontiers in cellular and infection microbiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Hydrogen Sulfide and Carbon Monoxide Tolerance in Bacteria.Antioxidants (Basel, Switzerland) · 2021
    Review
  14. Article
  15. HutW fromBiochemistry · 2021
    Article
  16. Biosynthesis of the modified tetrapyrroles-the pigments of life.The Journal of biological chemistry · 2020
    Review
  17. Review
  18. Article
  19. Looking beyond Typical Treatments for Atypical Mycobacteria.Antibiotics (Basel, Switzerland) · 2020
    Review
  20. Structure of aBiochemistry · 2019
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Shusuke NambuInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Aoba, Sendai 980-8577, Japan.
Toshitaka MatsuiInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Aoba, Sendai 980-8577, Japan.
Celia W GouldingDepartment of Molecular Biology and Biochemistry, University of California, Irvine, California 92697; Department of Pharmaceutical Sciences, University of California, Irvine, California 92697.
Satoshi TakahashiInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Aoba, Sendai 980-8577, Japan.
Masao Ikeda-SaitoInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Aoba, Sendai 980-8577, Japan. Electronic address: mis2@tagen.tohoku.ac.jp.
Tohoku University · JPUniversity of California, Irvine · US

Funding

Structural And Biochemical Characterization Of A Novel Mycobacterial Heme UptakeR01AI081161 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI GOULDING, CELIA · 2009 to 2013
$1.8M
NIAID NIH HHS AI081161NIAID NIH HHS R01 AI081161
6 · The paper itself

Abstract

MhuD is an oxygen-dependent heme-degrading enzyme from Mycobacterium tuberculosis with high sequence similarity (∼45%) to Staphylococcus aureus IsdG and IsdI. Spectroscopic and mutagenesis studies indicate that the catalytically active 1:1 heme-MhuD complex has an active site structure similar to those of IsdG and IsdI, including the nonplanarity (ruffling) of the heme group bound to the enzyme. Distinct from the canonical heme degradation, we have found that the MhuD catalysis does not generate CO. Product analyses by electrospray ionization-MS and NMR show that MhuD cleaves heme at the α-meso position but retains the meso-carbon atom at the cleavage site, which is removed by canonical heme oxygenases. The novel tetrapyrrole product of MhuD, termed "mycobilin," has an aldehyde group at the cleavage site and a carbonyl group at either the β-meso or the δ-meso position. Consequently, MhuD catalysis does not involve verdoheme, the key intermediate of ring cleavage by canonical heme oxygenase enzymes. Ruffled heme is apparently responsible for the heme degradation mechanism unique to MhuD. In addition, MhuD heme degradation without CO liberation is biologically significant as one of the signals of M. tuberculosis transition to dormancy is mediated by the production of host CO.

Indexed as

Gene Expression Regulation, BacterialBacterial ProteinsCarbon MonoxideCatalytic DomainHemeHeme Oxygenase (Decyclizing)Magnetic Resonance SpectroscopyModels, ChemicalMycobacterium tuberculosisNADPH-Ferrihemoprotein ReductaseOxygenasesSpectrometry, Mass, Electrospray IonizationSpectrum Analysis, RamanBacterial ProteinsCarbon MonoxideHemeHeme Oxygenase (Decyclizing)IsdG protein, Staphylococcus aureusNADPH-Ferrihemoprotein ReductaseOxygenases

Identifiers

PMID23420845
PMCPMC3617252
OpenAlexW1967719595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.